文献速递妇科产科

早期宫颈癌子宫切除术等待时间与生存:新冠疫情期间的临床启示

Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic.
PubMed 文献 · Gynecol Oncol · 2020-05-18

本研究为单中心回顾性观察研究,纳入2000至2017年间217例临床IA-IIA期宫颈癌患者,比较活检确诊后手术等待时间短于8周与不短于8周两组。经倾向评分加权后,长等待组无病生存期和总生存期与短等待组相似,提示8周等待可能与短期复发无关。

要点

  • 早期宫颈癌子宫切除等待≥8周未显著影响无病生存和总生存。
  • 长等待组与短等待组4.5年无病生存率分别为91.2%和90.7%(HR 1.11,P=0.818)。
  • Meta分析合并HR 0.96(95%CI 0.59-1.55),支持等待8周与DFS无显著关联。

核心结论

  • 早期宫颈癌患者子宫切除术等待8周可能与短期疾病复发无关。

研究设计与样本

  • 单中心回顾性观察研究,纳入2000至2017年217例临床IA-IIA期宫颈癌患者。
  • 按活检确诊到确定性手术等待时间分为短等待组(<8周,n=110)和长等待组(≥8周,n=107)。
  • 采用倾向评分逆概率治疗加权平衡两组人口学特征。
  • 附加系统文献综述与Meta分析,纳入三项研究。

主要发现

  • 加权模型(中位随访4.6年)中,长等待组4.5年无病生存率为91.2%,短等待组为90.7%(HR 1.11,95%CI 0.47-2.59,P=0.818)。
  • 长等待组总生存率为95.0%,短等待组为97.4%(HR 1.47,95%CI 0.50-4.31,P=0.487)。
  • Meta分析中,手术等待≥8周对无病生存的合并HR为0.96(95%CI 0.59-1.55)。

临床怎么用

  • 在新冠疫情期间医疗资源紧张时,早期宫颈癌子宫切除术可考虑推迟至8周。
  • 推迟决策应结合患者具体情况与医疗资源进行个体化评估。

局限性

  • 本研究为单中心回顾性观察性研究,样本量有限(N=217)。
  • 等待时间仅以8周为界二分,未分析更长等待时间的影响。
  • Meta分析仅纳入三项研究,证据强度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A global pandemic caused by a novel coronavirus (Covid-19) has created unique challenges to providing timely care for cancer patients. In early-stage cervical cancer, postponing hysterectomy for 6-8 weeks is suggested as a possible option in the Covid-19 burdened hospitals. Yet, literature examining the impact of surgery wait-time on survival in early-stage cervical cancer remains scarce. This study examined the association between surgery wait-time of 8 weeks and oncologic outcome in women with early-stage cervical cancer. METHODS: This is a single institution retrospective observational study at a tertiary referral medical center examining women who underwent primary hysterectomy or trachelectomy for clinical stage IA-IIA invasive cervical cancer between 2000 and 2017 (N = 217). Wait-time from the diagnosis of invasive cervical cancer via biopsy to definitive surgery was categorized as: short wait-time (<8 weeks; n = 110) versus long wait-time (≥8 weeks; n = 107). Propensity score inverse probability of treatment weighting was used to balance the measured demographics between the two groups, and disease-free survival (DFS) and overall survival (OS) were assessed. A systematic literature review with meta-analysis was additionally performed. RESULTS: In a weighted model (median follow-up, 4.6 years), women in the long wait-time group had DFS (4.5-year rates, 91.2% versus 90.7%, hazard ratio [HR] 1.11, 95% confidence interval [CI] 0.47-2.59, P = 0.818) and OS (95.0% versus 97.4%, HR 1.47, 95%CI 0.50-4.31, P = 0.487) similar to those in the short wait-time group. Three studies were examined for meta-analysis, and a pooled HR for surgery wait-time of ≥8 weeks on DFS was 0.96 (95%CI 0.59-1.55). CONCLUSION: Our study suggests that wait-time of 8 weeks for hysterectomy may not be associated with short-term disease recurrence in women with early-stage cervical cancer.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Matsuo K, Novatt H, Matsuzaki S, et al. Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic. Gynecol Oncol. 2020. PMID: 32425268. doi:10.1016/j.ygyno.2020.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。